Anzupgo Cream

Anzupgo Cream (Delgocitinib 20 mg/g) – Treatment for Chronic Hand Eczema

Anzupgo Cream is a prescription topical pan-Janus kinase (JAK) inhibitor indicated for the treatment of moderate to severe chronic hand eczema (CHE) in adults for whom topical corticosteroids are inadequate or inappropriate. It contains Delgocitinib 20 mg/g, an innovative non-steroidal anti-inflammatory medicine developed by LEO Pharma that specifically targets inflammatory pathways involved in chronic hand eczema.

Chronic hand eczema is one of the most difficult forms of eczema to manage and can significantly affect quality of life, causing persistent itching, redness, dryness, pain, cracking, and inflammation of the hands. Anzupgo Cream offers a targeted treatment approach that addresses multiple inflammatory pathways simultaneously, making it a valuable option for patients requiring steroid-sparing therapy.

Product Information

• Generic Name: Delgocitinib 20 mg/g Cream
• Drug Class: Topical Pan-Janus Kinase (JAK) Inhibitor
• Brand Reference: Anzupgo (LEO Pharma)
• Indication: Moderate to Severe Chronic Hand Eczema (CHE) in Adults
• Standard Dose: Apply a thin layer twice daily to affected areas of the hands or as prescribed by the treating physician.
• Form: Topical Cream
• Route: Topical
• Prescription: Yes
• Evidence: Approved in the United Kingdom and European Union for adults with moderate to severe chronic hand eczema inadequately controlled by topical corticosteroids. Clinical trials have demonstrated significant improvements in eczema severity, itch reduction, and skin healing in eligible patients.

Unlike topical corticosteroids that primarily suppress inflammation through steroid-mediated pathways, Delgocitinib works by inhibiting the activity of all four members of the Janus kinase family (JAK1, JAK2, JAK3, and TYK2). This pan-JAK inhibition helps reduce inflammatory signaling involved in chronic hand eczema, improving symptoms such as redness, scaling, fissures, itching, and skin discomfort while supporting restoration of the skin barrier.

Anzupgo Cream is particularly suitable for adults experiencing persistent hand eczema that interferes with occupational activities and daily living. Patients with chronic symptoms including painful cracks, dryness, thickened skin, recurrent flare-ups, and corticosteroid-resistant disease may benefit from treatment when prescribed by their healthcare provider.

Patients searching for Anzupgo Cream, Delgocitinib Cream, chronic hand eczema treatment, non-steroidal eczema cream, topical JAK inhibitor for eczema, or moderate to severe hand eczema medicine are referring to the same active ingredient and therapeutic indication. While Anzupgo is currently approved in the United Kingdom and European Union for chronic hand eczema, Delgocitinib continues to represent an important advancement in targeted dermatology treatments internationally.

Buy Anzupgo Cream online from a trusted pharmaceutical supplier offering genuine dermatology medicines, competitive pricing, secure ordering, and worldwide shipping where permitted by local regulations. Prescription medicines should only be used under the supervision of a qualified healthcare professional, with individualized treatment planning and regular follow-up assessments.

Frequently Asked Questions

What is Anzupgo Cream used for?

Anzupgo Cream is used for the treatment of moderate to severe chronic hand eczema in adults who have not responded adequately to topical corticosteroids or when corticosteroids are unsuitable.

What is the active ingredient in Anzupgo Cream?

Anzupgo contains Delgocitinib 20 mg/g, a topical pan-JAK inhibitor that helps reduce inflammation associated with chronic hand eczema.

Is Anzupgo Cream a steroid?

No. Anzupgo is a non-steroidal topical medicine and does not contain corticosteroids.

How does Delgocitinib work?

Delgocitinib inhibits multiple Janus kinase (JAK) pathways involved in skin inflammation, helping reduce redness, itching, scaling, and skin fissures associated with chronic hand eczema.

Can Anzupgo Cream be used long-term?

Treatment duration should always be determined by the prescribing healthcare professional based on treatment response and clinical evaluation.

What are the common side effects of Anzupgo Cream?

The most commonly reported adverse effects include mild application site reactions and nasopharyngitis. Patients should consult their healthcare provider regarding any persistent or severe symptoms experienced during treatment.

Is Anzupgo Cream available in the United States?

Anzupgo has received approval in the United Kingdom and European Union for chronic hand eczema. Regulatory approvals may differ between countries, and patients should consult local prescribing information regarding availability.